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AXONAL REGENERATION IN THE HEMISECTED ADULT RAT SPINAL CORD
K. Bhatt 1, M. Enomoto 2, T. Hirai 2, K. Shinomiya 2. 1 Imperial College
London, UK; 2 Tokyo Medical and Dental University, Tokyo
Background: Spinal Cord Injury causes a huge burden for patients, with
a lack of effective surgical treatment & continuous cost of care. Bone
Marrow Stromal Cells (BMSC) and artiﬁcial extracellular matrices have
been shown to aid recovery in various models. We proposed the combined
use of BMSCs with a Honeycomb Collagen (HC) matrix to aid axonal
regeneration.
Materials & Methods: In-vitro study of explanted rat Dorsal Root Ganglia
onto BMSC infused HC scaffolds compared against the HC control were
evaluated. Maximum neurite length after 10 days was calculated. The
study continued to an in-vivo study of spinal cord hemisection in rat
models, with the injury site being surgically implanted with HC or
BMSC+HC scaffolds. 4 weeks post injury the cords were evaluated for
injury site volume compared to total cord volume. Basso Beattie Bresnahan
score and sub score was used to analyse motor recovery.
Results: Explants showed a signiﬁcant difference in neurite length, with
BMSC + HC group producing 3x greater growth (p value 0.0004). The SCI
Injury model showed a tendency of BMSC+HC to have a smaller injury site
volume. Motor recovery was signiﬁcantly higher in the BMSC+HC group in
both the BBB score and BBB subscore (p ¼ 0.03 & p ¼ 0.005 respectively).
Conclusion: Wesuccessfully showed thatBMSCshaveefﬁcacycompared to
HC controls in both in-vitro and in-vivo axonal regeneration, with a func-
tional recovery being greater in the BMSC group. Therefore both structural
and cellular support is needed for a surgical intervention to aid recovery.THE ROLE OF FIBROBLAST GROWTH FACTOR SIGNALLING IN
OSTEOSARCOMA
S. Mahalingam, R. Al-Dabbagh, D. Weekes, A.E Grigoriadis. King’s College
London
Background: The mechanisms responsible for the development of oste-
osarcomas are unknown. Preliminary experiments using a mousemodel of
osteosarcoma (OS) suggest a role for ﬁbroblast growth factor (FGF) sig-
nalling in oncogenic transformation of osteoblasts. We hypothesise
a similar case in humans. We investigated the role of ﬁbroblast growth
factors and receptors (FGFRs) in the growth of human osteoblasts. Our
aims: to compare FGFR expression between normal human osteoblasts
(HOBs) and OS cells; compare effects of FGF on growth of HOBs and OS
cells; and establish a 3-dimensional culture model representing an in vivo
environment.
Methodology: Western blot analysis of FGFR expression was performed
on HOBs and 3 human OS cell lines (MG-63, Saos2, U2OS). Using cell
culture techniques, we investigated the effect of bFGF and SU5402 (FGFR
inhibitor) on cell transformation and proliferation. In parallel to these in
vitro experiments, we developed an in ovo model. Our system involves
grafting tumours (explants frommouse model) onto chick chorioallantoic-
membrane (CAM).
Results: FGFR1 and FGFR4 were overexpressed in OS cell lines compared
to HOBS. bFGF induced features of transformed cells in HOBs; this was
reversed by SU5402. bFGF increased proliferation of OS cells in comparison10.1016/j.ijsu.2011.03.004to HOBs. All tumours grafted onto the CAM, especially those treated with
bFGF, became vascularised.
Conclusion: This new evidence suggests a vital role for FGF signalling in
the pathogenesis of OS. Furthermore, the ﬁrst steps have been taken in
developing an in ovo tumour culture system. This can be developed to
study the effects of modulating exogenous factors on tumour growth.ARTERIAL FUNCTION IN PATIENTS WITH DIABETES MELLITUS
UNDERGOING CORONARY ARTERY BYPASS GRAFTING
Temitope Bademosi, T.A. Barker, M. Iafrancesco. Warwick University
Objectives: Type-2 diabetes mellitus is a risk factor for morbidity/
mortality following coronary artery bypass grafting (CABG), which may be
attributable in part to arterial stiffening. We aimed to identify if patients
with increased arterial stiffness pre-operatively had worse outcomes
following CABG, whilst also investigating the potential molecular deter-
minants of arterial stiffening within aortic biopsies.
Methods: Measurements of arterial stiffness, Pulse Wave Velocity, on 12
non-diabetics and 17 Type-2 diabetics were correlated with indirect
predictors of poor outcome followingCABG (peakpost-operative troponinT,
day 4 creatinine).Aortic biopsies were analysed by zymography for levels of
the extracellularmatrix enzymeMMP-2. Data are represented asmeans and
percentages. Results were assessed using appropriate statistical tests and
correlation coefﬁcients were calculated. P<0.05 was considered signiﬁcant.
Results: PWVwassigniﬁcantly increased indiabetics,13.92 (11.78-16.46)m/
s vs. non-diabetics 9.34 (8.70- 10.02) m/s, (p<0.001). In diabetics only,PWV
was signiﬁcantly and positively correlated with peak troponin T (rho¼0.65,
pvalue¼0.03) and day 4 creatinine (rho¼0.64, p value¼0.02). Analyses of the
aortic tissue indicated an increase in percentage MMP- 2 activity (50% vs.
30%) in diabetics vs. non-diabetics (not statistically signiﬁcant).
Conclusions: PWV may be a useful tool for predicting a group of diabetic
patients that have worse outcomes following CABG. Interventions to
reduce arterial stiffness in the future could be focused on this high-risk
subpopulation. A therapeutic target may include modulation of MMP-2
activity, a possible pathophysiology of aortic stiffening.THE EFFECT OF AORTIC GRAFTS ON TONOMETRIC MEASUREMENT OF
ARTERIAL COMPLIANCE
Adam Mulla 2, Thomas A. Barker 1,2, Robert S. Bonser 1,2, Mauro
Iafrancesco 1, Peter Nightingale 1, Malcolm H. Simms 1, John Townend 1,2,
Domenico Pagano 1,2. 1 University Hospital Birmingham NHS Foundation
Trust; 2 University of Birmingham
Objectives: The aorta buffers pulsatile cardiac output into peripheral non-
pulsatile ﬂow. Tonometric measurements of arterial compliance can
predict future cardiovascular events, but the segment of aorta responsible
for the pathophysiological effects of arterial stiffening is unknown. We
investigated this in patients with differing anatomical aortic segment
prosthetic replacements.
Methods: We measured tonometric carotid-femoral Pulse Wave Velocity
(PWV) using a Sphygmocor device in 4 patient groups: CONTROL subjects
with low cardiovascular risk; THORACIC patients with aortic root grafts;
ABDOMINAL patients with operated infra-renal aortic aneurysms;
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Adjustments between groups were made for age, sex, mean arterial
pressure, creatinine and the presence of diabetes using linear regression
analysis. PWV was represented as the mean [95% CI lower-upper].
Results: A total of 105 studies were performed, CONTROL n¼27,
THORACIC n¼30, ABDOMINAL n¼25, UNOPERATED n¼23. The ABDOM-
INAL group had an adjusted PWV of 11.9m/s [10.8-13.1], signiﬁcantly
higher than CONTROLS 8.8m/s [8.5-9.2] (p<0.001), THORACIC 8.8m/s [8.0-
9.6] (p<0.001), and UNOPERATED 8.9m/s [8.0-9.8] (p<0.001).
Conclusions: These data suggests that the replaced abdominal aorta
reduces arterial compliance. Thoracic grafting does not have an effect on
PWV indicating that the proximal aorta contributes less to tonometric
measurements of arterial stiffness. We provide a basis for future work to
investigate how prosthetic aortic replacement affects ventricular-arterial
coupling and the impact of pharmacological manipulation of vascular
function in such patients.PROGNOSTIC SIGNIFICANCE OF TOTAL DISEASE LENGTH IN
OESOPHAGEAL CANCER
J.D. Mason, L.l. Davies, T.D. Reid, M. Robinson, T.D. Crosby, S.A. Roberts,
W.G. Lewis. South East Wales Upper GI Cancer Network
Background: Oesophageal tumour length has long been considered an
important prognostic indicator in oesophageal cancer (OC), and typically
an operable tumour has been considered to be T1-3, N0-1, M0, with an
endoscopic deﬁned length of 5 cm or less.
Aims: The aim of this study was to test the hypothesis that endoluminal
ultrasound (EUS) deﬁned total length of disease (including both the
primary tumour and the position and number of proximal and distal
lymph nodes - ELoD) and the associated EUS lymph node metastasis count
(ELNMC) are better predictors of outcome than endoscopic OC length and
radiological TNM stage in patients undergoing potentially curative therapy
with either surgery or deﬁnitive chemoradiotherapy (dCRT).
Methods: 610 consecutive patients diagnosed with OC and managed by
a multidisciplinary teamwere staged by CT and EUS. The primary outcome
measure was survival from date of diagnosis.
Results: 302 patients received surgery and 308 patients received dCRT.
Univariable analysis revealed that survival was related to EUS T (p<0.001),
N (p<0.001), M1a (p¼0.041) stage, ELoD (p¼0.009), ELNMC (p<0.001),
and treatment type (p¼0.003). Multivariable analysis revealed two factors;
ELoD (HR 0.960 95% CI 0.923-0.999, p¼0.047) and ELNMC (HR 1.123, 95% CI
1.062-1.188, p<0.001) were independently associated with survival.
Conclusion: ELoD and ELNMC should become part of routine OC radio-
logical staging reports to optimise stage directed therapeutic outcomes.ROLE OF POSITRON EMISSION TOMOGRAPHY (PET) IN PANCREATIC
RESECTION FOR SUSPECTED PANCREATIC AND PERIAMPULLARY
CANCER
V. Allen, K.S. Gurusamy, A. Kalia, B.R. Davidson. Department of Surgery,
Royal Free Campus - UCL Medical School, 9th Floor Royal Free Hospital,
Pond Street, London. NW3 2QG
Background: A signiﬁcant proportion of patients undergo unnecessary
laparotomy because of incorrect diagnosis and understaging of pancreatic
and periampullary cancer.
Methods: A systematic review of studies assessing PET was performed.
Medline, Embase, Cochrane trials register, and Science Citation Index were
searched until November 2009. The gold standard test was laparotomy
with histological conﬁrmation. Meta-analysis was performed using
bivariate method and Littenberg-Moses method.
Results: Seven studies including 336 patients were included in the meta-
analysis for distinguishing benign from malignant disease. The summary
sensitivity and speciﬁcity were 0.892 and 0.745. This corresponds to a post-
test probability of 0.91 for a positive PET and 0.30 for a negative PET.
compared to a baseline probability of 0.75. Two studies including a total of
199 patients (who had undergone CT scan as standard work-up) were
included in the meta-analysis for assessing resectability with curativeintent. The summary sensitivity and speciﬁcity were 0.92 and 0.87. This
corresponds to a post-test probability of 0.56 for a positive PET (i.e. patient
has a 44% probability of curative resection if PET was positive) and 0.02 for
a negative PET (i.e. patient has a 98% probability of curative resection if PET
was negative) compared to a baseline probability of 0.15 (i.e. patient has
a 85%probability of curative resection if laparotomywas donewithout PET).
Conclusions: PET has no role in distinguishing benign and malignant
periampullary disease. A positive PET scan is unreliable but a negative PET
scan can conﬁrm curative resectability with high accuracy.AN ANALYSIS OF TUMOURIGENESIS IN HUMAN MESENCHYMAL STEM
CELLS EXPANDED IN VITRO
Clare Byrne. University of Aberdeen School of Medicine
5-10% of fractures demonstrate signiﬁcantly delayed healing or non-union.
Although skeletal ﬁxation has achieved limited success, no ideal treatment
for non-union exists1. One potential is the use of human mesenchymal
stem cells (hMSC's) to enhance fracture healing. While hMSC's display
immunosuppressive properties reducing the likelihood of rejection, side-
effects could include tumourigenesis2.
Objectives: 1. Do hMSC's become tumourigenic when expanded in
vitro and grown on agar?
2. Do time, cell concentration and passage number affect
tumourigenesis?
Materials & Methods: hMSC's were obtained from bone marrow aspi-
rates from iliac crests of patients undergoing surgical treatment for non-
union tibial fractures. Cells from 4 patients at 3 passages, positive (HCT
cells) and negative control lines (AA/CI cells), were seeded onto agar plates
at different concentrations. Plates were incubated at 37oC, 5% CO2 for 4
weeks. Tumour colony numbers (image 1) and tumourigenicity were
calculated weekly.
Image 1: Tumour colonyScale Bar: 20m ¼ 2cm
Results: 1. hMSC lines produced no colonies (p<0.001)
2. Higher cell concentrations result in increased colony numbers
(p<0.001)
3. Colony numbers decreased with time (p<0.001)
Conclusions: Tumourigenesis did not occur in hMSC's expanded in vitro.
These results may support existing studies conﬁrming hMSC's can be
safely expanded in vitro for therapeutic use.
clare.byrne.09@ucl.ac.uk: Institute of Orthopaedics, Royal National
Orthopaedic Hospital, Stanmore
